Laminin and its alpha 6 integrin receptor in the regulation of human hepatocellular carcinoma cell phenotypes.
- Author:
Tian-jing LU
1
;
Qing-yun ZHANG
;
Rou-li ZHOU
Author Information
- Publication Type:Journal Article
- MeSH: Antibodies, Monoclonal; pharmacology; Carcinoma, Hepatocellular; pathology; Cell Adhesion; drug effects; Humans; Integrin alpha6; immunology; physiology; Laminin; physiology; Liver Neoplasms; pathology; Phenotype; Receptors, Laminin; physiology; Tumor Cells, Cultured
- From: Chinese Journal of Oncology 2003;25(1):31-35
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the role of integrin alpha 6 in cell attachment, spread, survival/proliferation and differentiation of human hepatocellular carcinoma (HCC) BEL-7402 cells on various substrates by monoclonal antibody against the extracellular domain of alpha 6 subunit (IA6ED McAb).
METHODSThe effect of McAb on attachment and spread of BEL-7402 cells on LN or FN substrate was examined. MTT analysis was used to examine the cell survival/proliferation, gelatin zymography to the matrix metalloproteinases (MMPs) secreted by BEL-7402 cells, and microparticle immunoabsorbent kit to AFP secretion while the cells were cultured on LN-, FN- or Matrigel-coated substrates.
RESULTSThe cell attachment, spread and survival/proliferation were inhibited. Moreover importantly, the malignant cell dedifferentiation and abnormal differentiation on LN-coated substrate were also strongly inhibited by IA6ED McAb.
CONCLUSIONLN and integrin alpha 6 regulate human HCC cell phenotypes of survival/proliferation and differentiation. The phenotypes of dedifferentiation and abnormal differentiation can be reversed by blocking the interaction between integrin alpha 6 and LN using IA6ED McAb, which may lower metastatic potency of tumor cells.